ACTIVE

reMYND

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-6,6 M €+3,8 %over 1 year

Gross margin-217,2 k €-122,8 %over 1 year

Equity-83,6 k €+98,6 %over 1 year

Workforce21,1 ETP-43,7 %over 1 year

Identity

Source · BCE/KBO

reMYND is a Public limited company incorporated in 2002. Its main activity is: Technical testing and analysis. Its registered office is in Leuven. It employs on average 21,1 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0476.910.101
Incorporation: 15/02/2002
Legal form: Public limited company
Registered office: Gaston Geenslaan 1
3001 Leuven · FlandreSee on map
Contributed capital: 12 814 562,00 €
Latest accounts: 31/12/2025
Average workforce: 21,1 ETP

Activities (NACE)

71209Technical testing and analysis· main 71209Technical testing and analysis 72109Research and experimental development on natural sciences and engineering 72190Other research and experimental development on natural sciences and engineering 73100Advertising 74302Translation and interpretation activities

Joint committees (2)

Signals

Healthy social debts

Financials

Source · NBB, 21 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	-217,2 k €	-123%	954,2 k €	-13.1%	1,1 M €	-35.7%	1,7 M €	+157%	664,2 k €
EBITDA	-2,1 M €	-8.7%	-1,9 M €	-1.3%	-1,9 M €	-2.1%	-1,9 M €	+25.9%	-2,5 M €
Operating result	-6,5 M €	+0.9%	-6,5 M €	+15.9%	-7,7 M €	+6.7%	-8,3 M €	+12.5%	-9,5 M €
Net result	-6,6 M €	+3.8%	-6,8 M €	+21.4%	-8,7 M €	-7.4%	-8,1 M €	+12.5%	-9,3 M €
Balance sheet
Equity	-83,6 k €	+98.6%	-5,9 M €	-720%	950,6 k €	+131%	-3 M €	-163%	4,8 M €
Total assets	3,1 M €	+14.3%	2,8 M €	-56.4%	6,3 M €	+32.1%	4,8 M €	-35.9%	7,4 M €
Cash	1,3 M €	+187%	457,3 k €	-85.4%	3,1 M €	+26.3%	2,5 M €	-56.1%	5,6 M €
Debts	3,1 M €	-62.5%	8,4 M €	+67.6%	5 M €	-32.6%	7,4 M €	+253%	2,1 M €
Other
Workforce	21,1 ETP	-43.7%	37,5 ETP	-6.9%	40,3 ETP	-11.2%	45,4 ETP	-7.5%	49,1 ETP

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 10 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
KARGO0467.190.897Represented by Steven Winderickx	Director30/04/2025 → 30/05/2030
R.A.D. LIFE SCIENCES0541.871.395Represented by Rudy Dekeyser	Director30/04/2025 → 30/05/2030
KORYS MANAGEMENT0885.971.571Represented by David Devigne	Director30/10/2018 → 30/05/2030
NorthboundBio1008.524.836Represented by Florien Stam	Director20/01/2025 → 30/05/2030
Participatiemaatschappij Vlaanderen0455.777.660Represented by Tine Bekaert	Director27/04/2020 → 30/05/2030
Paul Van Dun	Director08/05/2019 → 30/05/2030Chairman of the board of directors02/05/2007 → 2019 accountsended
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by Goedele Ertveldt	Director04/12/2020 → 30/05/2030
Johan Cardoen	Director30/05/2024 → 30/05/2030
SysteemUnoDue0717.537.902Represented by Rudy De Keyser	Director01/06/2022 → 30/04/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
SUNATHIM0474.893.093Represented by Shetty Sunangal	Director01/06/2022 → 16/12/2023
Mustapha Leavenworth Bakali	Chairman of the board of directors22/07/2020 → 2022 accounts

Other companies at this address

Gaston Geenslaan 1 3001 Leuven

Company	CBE no.
Bio-Incubator Leuven● Active	0876.605.232
Community Building Arenberg● Active	1014.096.594
Creative Biolabs Belgium● Active	1028.942.544
DName-iT● Active	0506.754.823
Fisherman● Active	0804.287.079
Fishway● Active	0787.869.632
Formac Pharmaceuticals● Active	0892.914.395
IDA INTERNATIONAL● Active	1002.119.470
Lever Bio Belgium● Active	1039.455.958
Maatschap reMYND● Active	1019.655.090
miDiagnostics● Active	0641.984.602
Oxurion● Active	0881.620.924
PALEO● Active	0756.986.614
PARKEERGEBOUW● Active	1009.039.728
Pledge Therapeutics● Active	0726.743.301
Qmineral● Active	0837.633.897
Raya Therapeutic● Active	1003.128.171
ReGenesys● Active	0877.070.337
ReGenesys EU● Active	0544.577.301
ReWrite● Active	1016.891.283

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	08/06/2026	18/06/2025	28/06/2024	05/07/2023	29/08/2022	31/05/2021
General meeting	28/05/2026	30/05/2025	30/05/2024	30/05/2023	01/06/2022	28/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	28/05/2026	08/06/2026	Dutch	PDF
Abridged model	31/12/2024	30/05/2025	18/06/2025	Dutch	PDF
Abridged model	31/12/2023	30/05/2024	28/06/2024	Dutch	PDF
Abridged model	31/12/2022	30/05/2023	05/07/2023	Dutch	PDF
Abridged model	31/12/2021	01/06/2022	29/08/2022	Dutch	PDF
Abridged model	31/12/2020	28/04/2021	31/05/2021	Dutch	PDF
Abridged model	31/12/2019	27/04/2020	26/06/2020	Dutch	PDF
Abridged model	31/12/2018	08/05/2019	13/06/2019	Dutch	PDF
Abridged model	31/12/2017	24/04/2018	23/05/2018	Dutch	PDF
Abridged model	31/12/2016	28/04/2017	23/05/2017	Dutch	PDF
Abridged model	31/12/2015	27/04/2016	23/05/2016	Dutch	PDF
Abridged model	31/12/2014	07/05/2015	09/06/2015	Dutch	PDF
Abridged model	31/12/2013	04/04/2014	29/04/2014	Dutch	PDF
Abridged model	31/12/2012	26/04/2013	21/05/2013	Dutch	PDF
Full modelCorrection	31/12/2011	10/05/2012	28/05/2013	Dutch	PDF
Full model	31/12/2011	10/05/2012	28/06/2012	Dutch	PDF
Abridged model	31/12/2010	01/04/2011	29/04/2011	Dutch	PDF
Abridged model	31/12/2009	02/04/2010	27/04/2010	Dutch	PDF
Abridged model	31/12/2008	02/04/2009	17/04/2009	Dutch	PDF
Abridged model	31/12/2007	09/05/2008	26/05/2008	Dutch	PDF
Abridged model	31/12/2006	02/05/2007	08/05/2007	Dutch	PDF

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

9 active · 10 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
KARGO0467.190.897Represented by Steven Winderickx	Director30/04/2025 → 30/05/2030
R.A.D. LIFE SCIENCES0541.871.395Represented by Rudy Dekeyser	Director30/04/2025 → 30/05/2030
KORYS MANAGEMENT0885.971.571Represented by David Devigne	Director30/10/2018 → 30/05/2030
NorthboundBio1008.524.836Represented by Florien Stam	Director20/01/2025 → 30/05/2030
Participatiemaatschappij Vlaanderen0455.777.660Represented by Tine Bekaert	Director27/04/2020 → 30/05/2030
Paul Van Dun	Director08/05/2019 → 30/05/2030Chairman of the board of directors02/05/2007 → 2019 accountsended
SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT0253.445.063Represented by Goedele Ertveldt	Director04/12/2020 → 30/05/2030
Johan Cardoen	Director30/05/2024 → 30/05/2030
SysteemUnoDue0717.537.902Represented by Rudy De Keyser	Director01/06/2022 → 30/04/2025

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
SUNATHIM0474.893.093Represented by Shetty Sunangal	Director01/06/2022 → 16/12/2023
Mustapha Leavenworth Bakali	Chairman of the board of directors22/07/2020 → 2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates09/09/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/05/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares13/05/2025
KAPITAAL - AANDELEN
PDF
Mandates28/01/2025
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/04/2024
ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates05/04/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/02/2024
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/01/2024
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

KARGO

R.A.D. LIFE SCIENCES

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Participatiemaatschappij Vlaanderen

KORYS MANAGEMENT

NorthboundBio

Paul Van Dun

SysteemUnoDue

Johan Cardoen

SUNATHIM

Mustapha Leavenworth Bakali

Rudy Dekeyser

Show the 7 other mandates

20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027202820292030

reMYND

Gaston Geenslaan 1, 3001 Heverlee

Director

DirectorChairman of the board of directors

Director

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Gaston Geenslaan 1, 3001 HeverleeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00143101

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
reMYNDCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00143101

Events

2025
Annual accounts 2025-6,6 M €↑
2024
Annual accounts 2024-6,8 M €↑
2023
Annual accounts 2023-8,7 M €↓
2022
Annual accounts 2022-8,1 M €↑
2021
Annual accounts 2021-9,3 M €↓
2020
Annual accounts 2020-7,1 M €↓
2019
Annual accounts 2019-3,3 M €↓
2018
Annual accounts 2018-2 M €↓
2017
Annual accounts 20172,9 M €↑
2016
Annual accounts 2016-2,3 M €↓
2015
Annual accounts 2015-2,1 M €↑
2014
Annual accounts 2014-2,4 M €↓
2013
Annual accounts 2013-1,7 M €↓
2012
Annual accounts 20121,3 M €↓
2011
Annual accounts 20113,2 M €↑
2010
Annual accounts 2010-370,3 k €↓
2009
Annual accounts 20095,1 k €↓
2008
Annual accounts 20089,2 k €↑
2007
Annual accounts 20077,2 k €↓
2006
Annual accounts 200692,4 k €
15/02/2002
IncorporationPublic limited company

reMYND

Overview

Identity

Financials

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events